https://www.selleckchem.com/
The suggested prognostic panel can be utilized as a reliable biomarker to predict osteosarcoma patient survival rates. Although the treatment effect and availability of therapeutic options for advanced hepatocellular carcinoma (HCC) are limited, the downstaging strategy may improve patient prognosis. This study aimed to investigate the potential of combination therapy as a downstaging strategy for treating advanced HCC with portal vein tumor thrombus (PVTT). This retrospective case series included patients having advanced HCC with PVTT, who received the com
Like
Comment
Share
